A DIABLO–Elastic Net Cox Framework Reveals Prognostic Biomarkers and a Plasticity, Guidance, and Invasion Axis Driving Glioblastoma Progression
Cancer Informatics · 2026-10 · 25
DOI: 10.1177/11769351261501142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Informatics, online erschienen am 28.10.2026. Verfasst von Abdullah Al-Sultan und 1 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Glioblastoma (GBM) is the most common and lethal primary malignant brain tumour in adults, characterised by marked molecular heterogeneity, therapeutic resistance and a median overall survival of approximately 15 months. Improved prognostic biomarkers and a deeper understanding of the molecular mechanisms driving disease progression remain critical unmet needs.
Methods
A novel framework combining Data Integration Analysis and Biomarker discovery using Latent cOmponents (DIABLO) with Elastic Net Cox regression was applied to transcriptomic, proteomic, phosphoproteomic and miRNA data from the CPTAC GBM cohort. Prognostic performance was evaluated using Kaplan–Meier analysis, Harrell’s concordance index (C-index) and time-dependent ROC analysis. External validation was performed in four independent cohorts (TCGA GBM, GDC-TCGA GBM, CGGA-693 and CGGA-325), followed by benchmarking against published prognostic signatures.
Results
Multi-omics integration revealed a coordinated plasticity, guidance and invasion axis underlying GBM progression. The model identified a six-gene prognostic signature comprising CHI3L1, DRAXIN, HOXC9, EPHB2, SPP1 and ADAMTS4. In the discovery cohort, the signature significantly stratified patients by survival ( p = 0.0013), achieved a C-index of 0.758 and demonstrated strong predictive performance (1–3-year AUCs: 0.838, 0.838, and 0.750). The signature retained prognostic value across all four validation cohorts, remained an independent predictor of overall survival after adjustment for clinical covariates, and demonstrated competitive performance against published GBM prognostic models. Decision curve analysis further supported its potential clinical utility.
Conclusions
The proposed framework integrates multi-omics biomarker discovery with mechanistic characterization of GBM progression and identifies a reproducible prognostic signature with potential utility for patient risk stratification and clinical management.
Zitieren
APA
Al-Sultan, A., & Al-Rashidi, M. (2026). A DIABLO–Elastic Net Cox Framework Reveals Prognostic Biomarkers and a Plasticity, Guidance, and Invasion Axis Driving Glioblastoma Progression. Cancer Informatics, 25. https://doi.org/10.1177/11769351261501142
Vancouver
Al-Sultan A, Al-Rashidi M. A DIABLO–Elastic Net Cox Framework Reveals Prognostic Biomarkers and a Plasticity, Guidance, and Invasion Axis Driving Glioblastoma Progression. Cancer Informatics. 2026;25. doi:10.1177/11769351261501142
BibTeX
@article{AlSultan2026,
author = {Al-Sultan, Abdullah and Al-Rashidi, Mai},
title = {A DIABLO–Elastic Net Cox Framework Reveals Prognostic Biomarkers and a Plasticity, Guidance, and Invasion Axis Driving Glioblastoma Progression},
journal = {Cancer Informatics},
year = {2026},
volume = {25},
doi = {10.1177/11769351261501142}
}
EUVIMED